New: NCI-funded clinical trial search
Mednet Logo

Lancet Oncol. 2020 Feb 14

Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.

View Paper

Related Questions

How should you manage a COVID-19 infected/suspected patient who is receiving chemotherapy and cannot interrupt or delay their cancer treatment?

8
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Fred Hutchinson Cancer Research Center

This is difficult to answer specifically without further details. There certainly is accumulating evidence that patients with cancer, especially those receiving immunosuppressive chemotherapy, are at greater risk of COVID-19 infection if exposed, and a greater risk of serious and life-threatening co...